Results 271 to 280 of about 474,365 (309)
Some of the next articles are maybe not open access.
Current Opinion in Chemical Biology, 1999
Hormone replacement therapy is increasingly being used for purposes unrelated to the alleviation of menopausal symptoms, such as the prevention of osteoporosis and cardiovascular disease. Clinical trials, however, suggest that the one drug/many purposes concept may be too optimistic.
T, Kooistra, J J, Emeis
openaire +2 more sources
Hormone replacement therapy is increasingly being used for purposes unrelated to the alleviation of menopausal symptoms, such as the prevention of osteoporosis and cardiovascular disease. Clinical trials, however, suggest that the one drug/many purposes concept may be too optimistic.
T, Kooistra, J J, Emeis
openaire +2 more sources
HORMONAL THERAPY AND CHOLELITHIASIS
Obstetrical & Gynecological Survey, 1977This report is to alert the abdominal surgeon to a new factor responsible for a rising incidence of cholelithiasis in the younger woman. The cause of cholelithiasis has been explained on the basis of biochemical changes with mechanical obstruction. The role of estrogen-progesterone elevation in pregnancy with associated hypercholesteremia is well-known.
G N, Weiss, E B, Weiss
openaire +2 more sources
Journal of the American Academy of Orthopaedic Surgeons, 2004
An estimated 10 million women in the United States currently use hormone replacement therapy (HRT) for relief of menopausal symptoms or prevention of chronic disease conditions such as osteoporosis. 1 However, the early termination of the Women’s Health Initiative (WHI) study, which examined the use of estrogen as primary prevention for osteoporosis ...
Heather V, Lochner, Thomas A, Einhorn
openaire +2 more sources
An estimated 10 million women in the United States currently use hormone replacement therapy (HRT) for relief of menopausal symptoms or prevention of chronic disease conditions such as osteoporosis. 1 However, the early termination of the Women’s Health Initiative (WHI) study, which examined the use of estrogen as primary prevention for osteoporosis ...
Heather V, Lochner, Thomas A, Einhorn
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2006
HRT should not be used for the prevention or treatment of chronic disease (eg, heart disease, osteoporosis, dementia). HRT is effective in alleviating moderate to severe menopausal symptoms. Clinicians must be aware of the risks and benefits of HRT and discuss them thoroughly with their patients.
openaire +2 more sources
HRT should not be used for the prevention or treatment of chronic disease (eg, heart disease, osteoporosis, dementia). HRT is effective in alleviating moderate to severe menopausal symptoms. Clinicians must be aware of the risks and benefits of HRT and discuss them thoroughly with their patients.
openaire +2 more sources
Breast Cancer, 2002
Recently, the guidelines for adjuvant hormonal therapy for primary breast cancer were presented at the National Institute of Health Consensus Development Conference in November 2000 and at the 7th International Conference on Adjuvant Therapy of Primary Breast Cancer in February 2001. Adjuvant hormonal therapy should be offered basically to all patients
Yasuhiro, Tamaki +2 more
openaire +2 more sources
Recently, the guidelines for adjuvant hormonal therapy for primary breast cancer were presented at the National Institute of Health Consensus Development Conference in November 2000 and at the 7th International Conference on Adjuvant Therapy of Primary Breast Cancer in February 2001. Adjuvant hormonal therapy should be offered basically to all patients
Yasuhiro, Tamaki +2 more
openaire +2 more sources
HORMONAL THERAPY IN DERMATOLOGY
Dermatologic Clinics, 2001Hormonal therapy in dermatology is used primarily to reverse or diminish the effect of androgens, which are responsible for causing acne, hirsutism, and androgenetic alopecia. Although hormonal therapy is one of many treatments for acne, it is the only medical therapy available for hirsutism, and likely the only hope for the successful medical ...
openaire +2 more sources
Best Practice & Research Clinical Endocrinology & Metabolism, 2002
Since 1958 growth hormone (GH) has been used as substitution treatment for children with GH deficiency. At present, it is clear that a dose of 0.23 mg/kg/week can lead to a final height close to target height, but in view of the wide inter-individual variation, alternative regimens based on invidualizing the dosage with the help of prediction models ...
openaire +2 more sources
Since 1958 growth hormone (GH) has been used as substitution treatment for children with GH deficiency. At present, it is clear that a dose of 0.23 mg/kg/week can lead to a final height close to target height, but in view of the wide inter-individual variation, alternative regimens based on invidualizing the dosage with the help of prediction models ...
openaire +2 more sources
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?
Circulation, 2023Leslie Cho +2 more
exaly